Excelitas Technologies announces launch of X-Cite 120LEDmini for fluorescence illumination solutions

Compact Solution Delivers Powerful Broadband Illumination

Excelitas Technologies Corp., a global technology leader focused on delivering innovative, customized photonic solutions, today announces the X-Cite 120LEDmini – a compact white light LED source for fluorescence imaging applications. Through direct coupling, the X-Cite 120LEDmini provides efficient optical output, exceptional uniformity, and the highest performing coupling optics available.

The X-Cite 120LEDmini offers broad-spectrum coverage ranging from 370nm to 700nm with high excitation power for popular fluorophores including DAPI, GFP, mCherry, and Cy5. Through USB, TTL or manual control via speedDIAL, a standard component included with the system, the X-Cite 120LEDmini offers convenient control options for any instrument configuration, from basic to fully automated operation.

“We are committed to providing life science researchers and equipment manufacturers the most innovative and reliable technologies,” said Oliver Scheuss, Vice President of Solid State Lighting and UV/Microscopy at Excelitas Technologies. “Utilizing the latest in LED technology, we have combined efficient transmission optics and thermal management within a compact size to deliver an ideal solution with high performance and thermal stability at an attractive price point.”

The X-Cite 120LEDmini is a highly efficient, environmentally-friendly solution with zero mercury disposal and low energy consumption. An instant on/off capability minimizes photobleaching and phototoxicity in specimens while offering a compact solution for minimum space requirements. With zero consumables and virtually no maintenance, the X-Cite 120LEDmini allows researchers to focus on their research.

The X-Cite 120LEDmini will be on display at LASER World of Photonics, June 22-25, 2015 in Munich, Germany at booth #B1.103.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
COVID-19 mRNA vaccine linked to myocardial scarring in adolescents and young adults